What is the difference between Rhodiola rosea and Rhodiola crenulata?

Rhodiola rosea and Rhodiola crenulata are different species. Published human trials for adaptogenic and antifatigue effects used Rhodiola rosea, typically the SHR-5 extract standardized to rosavins and salidrosides. Rhodiola crenulata has a different phytochemical profile and is not considered equivalent.

What standardization should I look for?

Studies report that Rhodiola rosea extract standardized to at least 3% rosavins and 1% salidrosides (a 3:1 ratio) is the form used in the most rigorous trials. Look for products that specify both markers, not just one.

When and how should Rhodiola be taken?

Clinical trials used Rhodiola extract in the morning, often before demanding cognitive or physical tasks. Studies suggest timing before stress exposure may be more beneficial than evening use. The typical dose range studied is 170–680 mg/day of standardized extract.

Is Rhodiola safe long-term?

Short-term trials (up to 3 months) have found Rhodiola to be well tolerated. Long-term safety data are limited. Some individuals report mild stimulatory effects; it is generally not recommended for those with bipolar disorder. Consult a healthcare provider before use.

Moderate Evidence

Best Form of Rhodiola

Standardized Rhodiola rosea extract (SHR-5) is the form used in most published human trials, with studies reporting reduced fatigue and improved stress resilience.

Updated 2026 · Reviewed by Dr. Brennan Commerford, D.C.

All Forms Ranked by Evidence

1
95/ 100· Top TierBest by EvidenceFF Preferred
Rhodiola (Rhodiola rosea) Root Extract (4% Rosavins, 1% Salidroside)
Form: standardized-extract
—
Verification pending
Rhodiola Crenulata
Form: Extract
Evidence for this form is under review — no score is shown until it is verified.
—
Verification pending
Rhodiola Extract (5% Rosavins)
Form: Extract
Evidence for this form is under review — no score is shown until it is verified.
—
Verification pending
Rhodiola Root Powder
Form: Root Powder
Evidence for this form is under review — no score is shown until it is verified.
—
Verification pending
Rhodiola Rosea
Form: Standard
Evidence for this form is under review — no score is shown until it is verified.
—
Verification pending
Rhodiola Rosea Extract (3% Rosavins)
Form: Extract
Evidence for this form is under review — no score is shown until it is verified.

Editorial note

The SHR-5 extract of Rhodiola rosea, standardized to rosavins and salidrosides, has the strongest human trial evidence. A randomized double-blind placebo-controlled trial in 161 cadets found SHR-5 produced a pronounced antifatigue effect vs placebo (antifatigue index 1.038–1.020 vs 0.905, p<0.001; PMID 12725561). A student exam-period trial found significant improvements in physical fitness, mental fatigue, and well-being at 20 days (PMID 10839209).

All Forms Compared

standardized-extract

Best For

Adaptogenic stress support, mental fatigue, physical endurance

SHR-5 extract standardized to ≥3% rosavins and ≥1% salidrosides is the form used in the most rigorous human trials. Studies report antifatigue effects at 170–680 mg/day (PMID 12725561, PMID 10839209).

Extract 3% Rosavins

Best For

Adaptogenic support with standardized marker compounds

3% rosavin standardization is the traditional benchmark derived from historic Rhodiola research. Considered acceptable when the 3:1 rosavins:salidrosides ratio is maintained.

Extract 5% Rosavins

Best For

Higher-potency adaptogenic support

Higher rosavin concentration; less studied than 3% standardization in clinical trials. May allow lower capsule weights for equivalent marker content.

Root Powder

Best For

Not recommended for clinical-level adaptogenic support

Root powder lacks standardization for rosavins and salidrosides, resulting in highly variable active compound content between batches and suppliers.

Rhodiola Crenulata Extract

Best For

Not substitutable for Rhodiola rosea

Rhodiola crenulata is a different species with a higher salidroside:rosavin ratio. Published human trials for cognitive/fatigue outcomes used R. rosea; crenulata is not a direct substitute.

Frequently Asked Questions

What is the difference between Rhodiola rosea and Rhodiola crenulata?: Rhodiola rosea and Rhodiola crenulata are different species. Published human trials for adaptogenic and antifatigue effects used Rhodiola rosea, typically the SHR-5 extract standardized to rosavins and salidrosides. Rhodiola crenulata has a different phytochemical profile and is not considered equivalent.
What standardization should I look for?: Studies report that Rhodiola rosea extract standardized to at least 3% rosavins and 1% salidrosides (a 3:1 ratio) is the form used in the most rigorous trials. Look for products that specify both markers, not just one.
When and how should Rhodiola be taken?: Clinical trials used Rhodiola extract in the morning, often before demanding cognitive or physical tasks. Studies suggest timing before stress exposure may be more beneficial than evening use. The typical dose range studied is 170–680 mg/day of standardized extract.
Is Rhodiola safe long-term?: Short-term trials (up to 3 months) have found Rhodiola to be well tolerated. Long-term safety data are limited. Some individuals report mild stimulatory effects; it is generally not recommended for those with bipolar disorder. Consult a healthcare provider before use.

See how standardized-extract fits your formula

Preview a personalized formula using research-backed dosing.

Preview your formula →

Deep dive: standardized-extract research

Full ingredient spotlight with citations

View spotlight

FormulaForge formulates and sells supplements containing the ingredients discussed on this page. Our formulary recommendations are based on peer-reviewed bioavailability research. All cited studies are independently verifiable.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.